Press Releases

 Filter by Provider

An invite-only dinner brought AI builders and enterprise security leaders together to discuss identity, permissions, and governance for agent-based systems.

BW LPG Limited (“BW LPG”, the “Company”, OSE ticker code: “BWLPG.OL”), the world’s leading owner and operator of LPG vessels, announces that it has signed a contract for the construction of eight 90’cbm Panamax Very Large Gas Carriers (VLGCs), for a total consideration of about US$940 million, subject to the final technical specifications. The newbuildings are expected to be delivered sequentially from the start of 2029 until the second quarter of 2030.

Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced new data from its rare liver disease programs. Late-breaking results from the Phase 2b VISTAS study of volixibat in PSC and Phase 2b AZURE-1 study of brelovitug in HDV, alongside data featuring its established therapy, LIVMARLI® (maralixibat), in PFIC, were presented at the European Association for the Study of the Liver (EASL) International Liver Congress 2026.

NEW YORK CITY, NY / ACCESS Newswire / May 30, 2026 / New to The Street announces tonight's Bloomberg Television broadcast airing at 6:30 PM ET as sponsored programming across the United States, MENA, and Latin America.

The OpenRouter alternative starts at $10, is drop-in compatible with the OpenAI SDK, and routes to 13 providers from a single prepaid balance.

Liposuction continues to rank among the most popular cosmetic procedures in the world, helping patients remove stubborn fat deposits that often resist diet and exercise. However, many patients are now discovering that not all liposuction procedures are the same.

Taurus Management has reported increasing investor interest in the rapidly evolving pre IPO sector as technological innovation continues to reshape global markets and accelerate company growth.

The idea that any wealth we possess on this earth is given to us, and not ours to keep, encourages tithing and philanthropy-- principles that Amaradio has always been openly passionate about.

How organizations can build trust, emotional safety, and connection during periods of disruption and change

Latvia, May 30, 2026 -- As burnout becomes an epidemic among top-tier professionals, European startup Rocket Fungi is redefining cognitive enhancement. Founded on the principle that "Health is Wealth," the brand provides high-performers with lab-tested, EU-manufactured mushroom extracts in precision capsules, offering a sustainable alternative to the pharmaceutical quick-fixes of the past.

Retired physician and former health science professor Richard Ruhling has released *Health, Happiness & Destiny Come from Wise Choices*. The book highlights healthy lifestyle habits, especially diet, as key factors in longevity and wellness, while also exploring biblical prophecies and their connection to current events.

Computation Ltd., a Toronto-based technology services provider, reports rising demand for IT support and computer repair services across Canada. Businesses are increasingly prioritizing reliable technical support, server maintenance, cybersecurity, and device repairs to reduce downtime, enhance security, and protect critical data.

The Boxery announced a bulk-buy planning option for poly bubble mailers, helping larger buyers align replenishment with forecasted order volume, freight needs, and shipping supply budgets.

BrewPrecision publishes technical review of Turin Legato V2 espresso machine, analyzing its sub-$500 value proposition with dual PID controllers, adjustable over-pressure valve, and hybrid brew boiler + thermoblock heating system for home baristas.

NEW YORK, NY - In a time when criminal justice reform, youth violence, and systemic inequality remain at the forefront of national conversation, Locked Up and Put Away: My 10 Years as a Juvenile Counselor by Booker Geez emerges as a powerful and deeply relevant new release that is resonating with readers across the country.

A frozen pipe in a Niwot home at three in the morning gets fixed faster when the truck is already five miles away rather than twenty. Boulder Valley’s geography stretches from south Boulder up through Gunbarrel, Niwot, and into Longmont, and a single dispatch center can’t cover all of it equally. Restoration Logistics has just stationed additional rapid-response trucks throughout the valley to address that specific gap. Drivers now sit closer to the addresses they actually serve, rather than fighting Diagonal Highway traffic to reach them from a central depot.

Cornelius, NC - Horizon Psychological Services is pleased to announce that Michael R. Youron, M.A., has attained independent licensure as a Licensed Psychological Associate (LPA). The milestone allows Mr. Youron to deliver psychological services independently, expanding access to experienced mental health care for individuals and families across the Lake Norman and Charlotte region.

NEW YORK, May 30, 2026 (GLOBE NEWSWIRE) --

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Sportradar Group AG (NASDAQ: SRAD) Class A ordinary shares between November 7, 2024 and April 21, 2026, both dates inclusive (the “Class Period”), have until July 17, 2026 to seek appointment as lead plaintiff of the Sportradar class action lawsuit. Captioned Smale v. Sportradar Group AG, No. 26-cv-04112 (S.D.N.Y.), the Sportradar class action lawsuit charges Sportradar as well as certain of Sportradar’s top executive officers with violations of the Securities Exchange Act of 1934.

The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Commvault Systems, Inc. (NASDAQ: CVLT) securities between April 29, 2025 and January 26, 2026, inclusive (the “Class Period”), have until July 17, 2026 to seek appointment as lead plaintiff of the Commvault class action lawsuit. Captioned Imbert v. Commvault Systems, Inc., No. 26-cv-05654 (D.N.J.), the Commvault class action lawsuit charges Commvault as well as certain of Commvault’s top current and former executive officers with violations of the Securities Exchange Act of 1934.

Canada, May 30, 2026 -- LGG Media, a leading performance marketing agency, today announced it has been recognized with a prestigious 2026 Google Ads Impact Award. The award celebrates LGG Media's innovative approach to leveraging Google Ads to deliver exceptional, measurable results for its clients, specifically a national health insurance brokerage.

In partnership with Utah Film Center, Woodbine Food Hall will be hosting outdoor movies throughout the summer

CEO Shay Benzvi Highlights Growing Demand for Sustainable Renovation, ADU Construction, and Energy-Efficient Home Improvements

PR to SKY, a New York-based PR and outdoor media agency, is offering access to five premium Times Square billboards during the FIFA World Cup 2026. Packages start at $9,500 per day and include creative, production, and PR support for brands seeking global exposure.

HANGZHOU, CHINA / ACCESS Newswire / May 30, 2026 / As global drinkware supply chains evolve, brands are prioritizing manufacturing partners with stable delivery, flexible production, and long-term resilience. In response, Everich is expanding its global manufacturing network, strengthening R&D capabilities, and optimizing integrated supply chain systems to better support OEM and ODM customers worldwide.

My Passport Hub explains how passport applicants can evaluate online support services, understand their role, and use them safely during application preparation.

GRAND RAPIDS, MI - May 30, 2026 - When TikTok introduced the world to short-form video discovery, it changed something fundamental about how people find things they trust. You didn't search for a creator. You scrolled until one found you — and when they did, you already felt like you knew them before you ever clicked follow.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Affected SRAD Investor Summary

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal trial, which showed that CABOMETYX® (cabozantinib) provided significant improvements in progression-free survival (PFS) versus placebo in patients with previously treated advanced neuroendocrine tumors (NET) regardless of functional status. These data will be presented at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting to be held from May 29 – June 2 in Chicago.

Massive Bio today announced the next-generation product suite within Reticulum Nexus™, introducing a coordinated set of AI agents, intelligent calculators, signal engines, patient navigation tools, and physician referral workflows designed to move oncology access from fragmented trial matching to closed-loop orchestration.

BRUSSELS, May 30, 2026 (GLOBE NEWSWIRE) -- Today, vapers, former smokers, and harm reduction advocates mark World Vape Day 2026. The theme this year is One Switch – Everyone Wins. It is not a slogan. It is what the data shows.

Company introduces a faster, mobile-optimized website designed to simplify access to IPTV services and customer resources.

Designed around the “Bring On The Mess” philosophy, the new wipes are larger than most leading brands by sheet dimensions, formulated with 99% purified water and coconut extract, and independently tested for safety by Intertek

MediaRise is now offering "done-for-you" multichannel content marketing campaigns for small and medium-sized businesses in New York City and Westchester, distributing branded content across more than 300 platforms to support long-term organic visibility.

DUBAI, UAE / ACCESS Newswire / May 30, 2026 / As global demand for artificial intelligence infrastructure accelerates at unprecedented speed, Asprofin Bank Corporation has announced it is evaluating a large-scale sovereign data center programme across three strategic sites in the United Arab Emirates.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the launch of the PRECISION Challenge, a national initiative engineered to accelerate the next generation of oncology breakthroughs leveraging its foundational model. The PRECISION Challenge aims to unlock breakthroughs in oncology at scale by providing access to data, funding, and expertise to multidisciplinary teams around the world who seek to make bold advances in cancer treatment and improve patient outcomes.

One of the most common questions patients ask during a body contouring consultation is whether they should choose a tummy tuck, liposuction, or a combination of both procedures.

Bluewater launches Café Station 1, a water purification and mineralisation system for cafés. The system removes 99.7% of contaminants, re-mineralises water, and allows real-time TDS adjustment via mobile app.

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

NEW YORK, NY - May 30, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against AeroVironment, Inc. (“AeroVironment” or the “Company”) (NASDAQ: AVAV) on behalf of investors that purchased or otherwise acquired AeroVironment securities between June 25, 2025 and March 10, 2026 (the “Class Period”).

Summit Therapeutics Inc. (NASDAQ: SMMT) today presented new results from the AK112-206 trial (NCT05382442), a global, open-label, multicenter Phase II study in first-line metastatic colorectal cancer (mCRC) co-sponsored by Summit and Akeso, featuring the novel, potential first-in-class investigational bispecific antibody ivonescimab. The data were presented today at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago.

Veracyte, Inc. (Nasdaq: VCYT), a leading cancer diagnostics company, today announced results from the ENZAMET trial presented at the 2026 ASCO Annual Meeting. The analysis demonstrates that the Decipher Prostate test identifies which men with metastatic prostate cancer benefit from adding the chemotherapy docetaxel to standard hormonal therapy (ADT plus enzalutamide), known as triplet therapy, and who can safely avoid it, providing the first Level 1B 1 evidence for a genomic test guiding this decision. Complementary data presented at the meeting also reinforce Decipher Prostate's clinical utility in high-risk localized disease.

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3.

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the introduction of Tempus Preview, an application providing rapid, clinically significant insights that close the gap between the time of order and delivery of insights. Representing a significant paradigm shift in precision oncology workflows, Tempus Preview offers preliminary results in the critical window between when a diagnostic test is ordered and when final sequencing results are delivered by surfacing key mutation predictions within approximately 24 hours of tissue receipt.

Immunome, Inc. (Nasdaq: IMNM), a biotechnology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced detailed efficacy and safety results from RINGSIDE, the global, randomized, double-blind, placebo-controlled Phase 3 trial of varegacestat in patients with progressing desmoid tumors. The data are being presented today in an oral abstract session at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. Immunome submitted an NDA for varegacestat to the FDA in April 2026.

Pfizer Inc. (NYSE: PFE) today announced detailed results from the pivotal Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), an androgen receptor pathway inhibitor (ARPI), in men with homologous recombination repair (HRR) gene-mutated metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC). These results will be presented today in a late-breaking oral presentation (Abstract LBA5007) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting and simultaneously published in The New England Journal of Medicine.

Tune Therapeutics, a leading epigenome editing company, presented new data today at the European Association for the Study of Liver (EASL) Congress in Barcelona, Spain, demonstrating the first clinical evidence of epigenetic silencing in hepatitis B virus (HBV).

Houston, Texas and Tuebingen, Germany, May 30, 2026 – Immatics N.V. (NASDAQ: IMTX, “Immatics” or the “Company”), the global leader in precision targeting of PRAME with multiple clinical-stage programs spanning cell therapies and bispecifics, today announced updated Phase 1 data for its IMA203CD8 PRAME TCR T-cell therapy in gynecologic cancers and synovial sarcoma at the Annual Meeting of the American Society for Clinical Oncology (ASCO) in Chicago, IL, USA. One-time infusion of IMA203CD8 demonstrated meaningful clinical activity across different tumor types as well as manageable tolerability. The broad expression of PRAME in more than 50 cancers further supports the continued development of IMA203CD8 in multiple PRAME-positive solid tumors.

WOBURN, Mass., May 30, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, today presented 3-year landmark overall survival data from the IGNYTE clinical trial of RP1 plus nivolumab in patients with anti-PD-1 failed melanoma during an oral session at the 2026 American Society of Clinical Oncology annual meeting.